Cargando…

[(18)F]FMISO PET/CT as a preoperative prognostic factor in patients with pancreatic cancer

BACKGROUND: While [(18)F]fluoromisonidazole (FMISO), a representative PET tracer to detect hypoxia, is reported to be able to prospect the prognosis after treatment for various types of cancers, the relation is unclear for pancreatic cancer. The aim of this study is to assess the feasibility of [(18...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamane, Tomohiko, Aikawa, Masayasu, Yasuda, Masanori, Fukushima, Kenji, Seto, Akira, Okamoto, Koujun, Koyama, Isamu, Kuji, Ichiei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509312/ https://www.ncbi.nlm.nih.gov/pubmed/31073705 http://dx.doi.org/10.1186/s13550-019-0507-8

Ejemplares similares

Can the function of the tubarial glands be evaluated using [(99m)Tc]pertechnetate SPECT/CT, [(18)F]FDG PET/CT, and [(11)C]methionine PET/CT?
por: Matsusaka, Yohji, et al.
Publicado: (2021)

Atlas of non-pathological solitary or asymmetrical skeletal muscle uptake in [(18)F]FDG-PET
por: Yamane, Tomohiko, et al.
Publicado: (2022)

Quantification of bone metabolic activity in the natural course of fractural lesions measured by quantitative SPECT/CT
por: Yamane, Tomohiko, et al.
Publicado: (2023)

Satisfied quantitative value can be acquired by short-time bone SPECT/CT using a whole-body cadmium–zinc–telluride gamma camera
por: Yamane, Tomohiko, et al.
Publicado: (2021)

Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer
por: Kuji, Ichiei, et al.
Publicado: (2017)

Usefulness of FMISO—PET for Glioma Analysis
por: Kobayashi, Hiroyuki, et al.
Publicado: (2013)

First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer
por: Thureau, Sébastien, et al.
Publicado: (2021)

Voxel based comparison and texture analysis of (18)F-FDG and (18)F-FMISO PET of patients with head-and-neck cancer
por: Kroenke, Markus, et al.
Publicado: (2019)

Biodistribution and radiation dosimetry of the novel hypoxia PET probe [(18)F]DiFA and comparison with [(18)F]FMISO
por: Watanabe, Shiro, et al.
Publicado: (2019)

Diffuse FDG uptake in the bilateral lungs: hypersensitivity pneumonitis supported by low-dose CT findings
por: Goto, Shun, et al.
Publicado: (2022)

Local relapse of nasopharyngeal cancer and Voxel-based analysis of FMISO uptake using PET with semiconductor detectors
por: Nishikawa, Yukiko, et al.
Publicado: (2017)

Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapy
por: Watanabe, Shiro, et al.
Publicado: (2019)

Kinetic Evaluation of the Hypoxia Radiotracers [(18)F]FMISO and [(18)F]FAZA in Dogs with Spontaneous Tumors Using Dynamic PET/CT Imaging
por: Choen, Sangkyung, et al.
Publicado: (2022)

Monitoring Tumor Hypoxia Using (18)F-FMISO PET and Pharmacokinetics Modeling after Photodynamic Therapy
por: Tong, Xiao, et al.
Publicado: (2016)

Value of (18)F-FDG-PET to predict PD-L1 expression and outcomes of PD-1 inhibition therapy in human cancers
por: Kaira, Kyoichi, et al.
Publicado: (2021)

Noninvasive evaluation of (18)F-FDG/(18)F-FMISO-based Micro PET in monitoring hepatic metastasis of colorectal cancer
por: Zhang, Mingyu, et al.
Publicado: (2018)

Quantitative MRI to Characterize Hypoxic Tumors in Comparison to FMISO PET/CT for Radiotherapy in Oropharynx Cancers
por: Gouel, Pierrick, et al.
Publicado: (2023)

A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using (18)F-FMISO-PET
por: Rockne, Russell C., et al.
Publicado: (2015)

Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and (18)F-FMISO PET
por: Huang, Shiliang, et al.
Publicado: (2021)

Synthesis of [(18)F]FMISO, a hypoxia-specific imaging probe for PET, an overview from a radiochemist’s perspective
por: Kniess, Torsten, et al.
Publicado: (2023)

Evaluation of (18)F-FMISO PET and (18)F-FDG PET Scans in Assessing the Therapeutic Response of Patients With Metastatic Colorectal Cancer Treated With Anti-Angiogenic Therapy
por: Lee, Sze Ting, et al.
Publicado: (2021)

[(18)F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [(18)F]FDG PET/CT approach
por: Tanguy, Julie, et al.
Publicado: (2021)

The role of necrosis, acute hypoxia and chronic hypoxia in (18)F-FMISO PET image contrast: a computational modelling study
por: Warren, Daniel R, et al.
Publicado: (2016)

Repurposing (18)F-FMISO as a PET tracer for translational imaging of nitroreductase-based gene directed enzyme prodrug therapy
por: Ruiz de Garibay, Gorka, et al.
Publicado: (2021)

(18)F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy
por: Carles, Montserrat, et al.
Publicado: (2021)

Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET
por: Wiedenmann, Nicole, et al.
Publicado: (2018)

FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer
por: Thureau, Sébastien, et al.
Publicado: (2018)

ANGI-1 ASSESSING THE THERAPEUTIC EFFECT OF BEVACIZUMAB USING FMISO-PET IN GBM THERAPY
por: Suzuki, Tomoya, et al.
Publicado: (2022)

Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET
por: Wiedenmann, Nicole, et al.
Publicado: (2018)

Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI, (18)F-FMISO PET, and (18)F-FLT PET in Relation to Contrast Enhancement in Newly Diagnosed Glioblastoma
por: Collet, Solène, et al.
Publicado: (2021)

FMISO-PET-derived brain oxygen tension maps: application to glioblastoma and less aggressive gliomas
por: Chakhoyan, Ararat, et al.
Publicado: (2017)

In vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab
por: Ueda, Shigeto, et al.
Publicado: (2016)

Intracellular hypoxia measured by (18)F-fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen receptor-positive breast cancer
por: Asano, Aya, et al.
Publicado: (2018)

Sequential [(18)F]FDG-[(18)F]FMISO PET and Multiparametric MRI at 3T for Insights into Breast Cancer Heterogeneity and Correlation with Patient Outcomes: First Clinical Experience
por: Andrzejewski, Piotr, et al.
Publicado: (2019)

Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693)
por: Asano, Aya, et al.
Publicado: (2018)

Increased [(18)F]FMISO accumulation under hypoxia by multidrug-resistant protein 1 inhibitors
por: Shimizu, Yoichi, et al.
Publicado: (2021)

Preoperative Evaluation of Renal Cell Carcinoma by Using 18F-FDG PET/CT
por: Takahashi, Miwako, et al.
Publicado: (2015)

Comparison of DCE‐MRI kinetic parameters and FMISO‐PET uptake parameters in head and neck cancer patients
por: Simoncic, Urban, et al.
Publicado: (2017)

Targeting Hypoxia Using Evofosfamide and Companion Hypoxia Imaging of FMISO-PET in Advanced Biliary Tract Cancer
por: Yoon, Jeesun, et al.
Publicado: (2021)

Monitoring therapeutic efficacy of sunitinib using [(18)F]FDG and [(18)F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma
por: Thézé, Benoît, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tq5gur6rf850ljmn7phl0ir0vt